Actionable trade ideas with defined risk and time horizons.
Curated trade ideas across equities, options, and other instruments, featuring clear directional bias, time horizon, and risk considerations. Trade ideas are designed to align market context, technical structure, and risk management principles.
6,033 total articles
Micron surged into new territory after the 245TB Micron 6600 ION SSD and accelerating memory price inflation. Fundamentals are solid - $10.3B in free cash flow, ROE north of 33% and a sub-0.15 debt/equity - but the stock is stretched: current price $642.66, 52-week high $651.74, RSI ~82. My trade: trim size at $642.66, take profits to lock gains, r…
Lam Research reported record Q3 revenue of $5.84B and raised guidance, with memory capex and AI demand driving order flow. At a market cap near $348B and P/E ~48, the stock is richly priced but justified by roughly 30% growth expectations, exceptional returns on capital and improving margins. Trade plan: enter at $280.00, target $365.00, stop $245.…
Microsoft is transitioning from a narrative-weighted AI bet to a monetization-focused strategy. With a $3.05 trillion market cap, strong free cash flow ($72.9B), low leverage and enterprise-first distribution, MSFT looks buyable on dips. This trade expects AI revenue conversion to accelerate over the next 180 trading days as Microsoft reduces singl…
Alphabet is trading at an implied market cap of roughly $460B and sits at the center of a multiyear AI replatforming. This trade idea argues for a controlled long position that leans on Alphabet's enterprise AI lock-in, ad resilience and cloud AI momentum, while acknowledging regulatory and competitive headwinds. Exact trade plan included for a lon…
Fresenius Medical Care (FMS) is trading near its 52-week low while carrying a sub-1 P/B and single-digit P/E relative to its longer-term profile. Technicals are deeply oversold, and the stock yields roughly 2.5% with an upcoming ex-dividend date. This trade idea sets a precise entry, stop and target for a long-term rebound play over 180 trading day…
SEMHF has pulled back into the low $40s amid heavy shorting and technical weakness. The company’s razor-and-blades revenue mix (equipment sales followed by recurring consumables and service) suggests outsized recovery potential if China volumes and service contracts normalize. This trade targets a mean reversion toward the 50-day average and beyond…
Charter rates for LPG carriers have moved beyond the levels that underpinned my prior bull case. Dorian LPG's balance sheet, cash flow generation, and a healthy dividend create a favorable risk-reward for a mid-term long trade. Entry at $39.82, stop at $36.00, target $48.00 (mid-term 45 trading days).
Viking Therapeutics (VKTX) is a small-cap clinical-stage biotech with an injectable GLP-1/GIP dual agonist, VK2735, that has shown rapid weight loss and tolerability in early data. The market is pricing in big upside: the Street consensus sits near $93.59, implying roughly 170% from today's ~$30.87. This trade idea outlines a long position sized fo…
Zoom is trading near $108 after a steady recovery. The company now shows enterprise traction, high free cash flow ($1.92B trailing), strong returns on capital, and a clean balance sheet. We recommend a long trade targeting $132 over a 180-trading-day horizon with a $95 stop, balancing momentum with valuation and regulatory risks.
KKR trades at about $102 with a market cap near $90.7B but carries a private-assets engine and an expanding insurance business that together produce recurring, less-cyclical fee revenue and outsized realizations. Near-term headlines around private credit are noisy; the buy thesis: durable fee growth, attractive realizations (example: Atlantic Aviat…
Shares of AngloGold Ashanti (AU) have pulled back on headline risk tied to Ghana. The business fundamentals - $46.3B market cap, a 3.9% dividend yield, and a mid-teens P/E - argue the selloff is more sentiment than reality. This trade idea outlines a mid-term (45 trading days) swing long with a clear entry, stop, and target while flagging the gover…
Micron's share price has raced higher on AI-driven demand, but the stock sits at elevated valuation multiples, an overbought technical profile, and a memory cycle that historically reverses sharply. I outline three concrete reasons to sell, provide an actionable mid-term trade plan, and list the catalysts that could trigger a pullback as well as wh…
Estee Lauder (EL) has been swinging from 52-week extremes and is sitting in a technical pocket that favors a disciplined long swing. Valuation metrics (EV/EBITDA ~13.9, P/S ~1.93) and steady free cash flow ($1.285B) mean the risk/reward looks attractive on a measured entry after recent headline-driven selloffs. This trade idea lays out a concrete e…
Nektar (NKTR) rallied from a $7.99 low in mid-2025 to roughly $86 today, yet the market is pricing the company like a pure-play development-stage drugmaker with limited cash and negative free cash flow. I lay out a long trade with entry, stop, and target, plus the catalysts and legal risks that will determine the next leg of performance.
Central Puerto (CEPU) is trading at a bargain relative to its earnings power and offers optionality beyond thermal power through natural gas transport and renewables. With a market cap of roughly $2.42B and a PE of 7.7, the stock looks attractive for a risk-managed long trade over the next 180 trading days. We lay out an entry at $14.53, a stop at …
Lockheed Martin plunged after a Q1 2026 earnings miss and brief negative free cash flow, but management reaffirmed full-year guidance. The stock is trading well below its 50- and 20-day averages, RSI is deeply oversold, and defense spending tailwinds remain intact. This trade idea proposes a long with a disciplined stop, targeting a recovery toward…
Opera (OPRA) looks buyable after a string of positive fundamental and technical signals: reasonable valuation ($1.68B market cap, PE ~14.8), a 4.12% yield, falling short interest, and bullish technical momentum. This is a tactical swing idea: enter $18.80, target $22.00 (mid term - 45 trading days), stop $17.00. Risk/reward favors the long, but wat…
General Dynamics (GD) has the balance-sheet strength, free cash flow and program exposure to benefit from elevated U.S. and allied defense spending. The stock looks actionable on a pullback with an asymmetric risk/reward: steady cash generation and a modest valuation versus growth and budget upside suggest a swing trade opportunity over the next 45…
Toll Brothers (TOL) looks attractively valued today after a pullback from its 52-week high. Strong ROE, modest leverage and an enterprise value that implies mid-single-digit EBITDA multiples give room for upside. This is a tactical long with a controlled stop: favorable risk/reward if you buy on a near-term dip and expect recovery over the next 45 …
Meta's stock has pulled back on headlines about a huge 2026 AI capex program and investor uncertainty over near-term ROI. Fundamentals remain strong: $56.3B revenue in Q1 2026 (+33% YoY), $48.25B in free cash flow, low leverage and a $1.54T market cap. The selloff is driven by fear around a $125-145B 2026 capex plan. We view that fear as a misprici…
Napco Security Technologies presents a pragmatic buy set-up at current levels. The company trades with a clean balance sheet, positive free cash flow ($53.66M), and high return metrics (ROE ~25.7%) despite near-term legal overhang and distributor turbulence. We view $41.53 as a fair-value entry for a long-term trade targeting a fundamental re-ratin…
Amazon trades like a growth story priced for near-perfect AI ROI. Balance-sheet strength and free cash flow mask valuation strain: market cap ~$2.98T, P/E ~32.5, EV/EBITDA ~36.9, and an RSI north of 80. This trade proposes a short entry at $277.32 with a $305 stop and a $230 target over a mid-term horizon (45 trading days), pairing fundamental skep…
Lululemon's share price has collapsed to the low $130s after guidance concerns and CEO transition jitters. Fundamentals remain solid: $15.7B market cap, trailing P/E below 10, $922M annual free cash flow, and high ROE. Technicals show oversold conditions. This trade lays out an entry at $130.78, a stop at $120, and a $190 target over a 180-trading-…
Intel has gone from pariah to poster child for the AI cycle in months. Technical momentum, accelerating demand for CPUs that orchestrate agentic AI, and fresh foundry/partner chatter give an asymmetric swing trade setup near $99.50. Valuation is rich for a legacy name, but short-interest, strong volume, and specific catalysts make a high-probabilit…
JAKKS Pacific (JAKK) looks mispriced versus the operational improvements and near-term product catalysts on the horizon. With gross margins at a 15-year high, a debt-free balance sheet, and fresh anime and entertainment licensing partnerships, the risk-reward favors a tactical long. This note lays out an entry, stop and target with a mid-term horiz…
